3D bioprinting spatiotemporally defined patterns of growth factors to tightly control tissue regeneration

Therapeutic growth factor delivery typically requires supraphysiological dosages, which can cause undesirable off-target effects. The aim of this study was to 3D bioprint implants containing spatiotemporally defined patterns of growth factors optimized for coupled angiogenesis and osteogenesis. Usin...

Full description

Saved in:
Bibliographic Details
Published inScience advances Vol. 6; no. 33; p. eabb5093
Main Authors Freeman, Fiona E, Pitacco, Pierluca, van Dommelen, Lieke H A, Nulty, Jessica, Browe, David C, Shin, Jung-Youn, Alsberg, Eben, Kelly, Daniel J
Format Journal Article
LanguageEnglish
Published United States American Association for the Advancement of Science 01.08.2020
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Therapeutic growth factor delivery typically requires supraphysiological dosages, which can cause undesirable off-target effects. The aim of this study was to 3D bioprint implants containing spatiotemporally defined patterns of growth factors optimized for coupled angiogenesis and osteogenesis. Using nanoparticle functionalized bioinks, it was possible to print implants with distinct growth factor patterns and release profiles spanning from days to weeks. The extent of angiogenesis in vivo depended on the spatial presentation of vascular endothelial growth factor (VEGF). Higher levels of vessel invasion were observed in implants containing a spatial gradient of VEGF compared to those homogenously loaded with the same total amount of protein. Printed implants containing a gradient of VEGF, coupled with spatially defined BMP-2 localization and release kinetics, accelerated large bone defect healing with little heterotopic bone formation. This demonstrates the potential of growth factor printing, a putative point of care therapy, for tightly controlled tissue regeneration.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:2375-2548
2375-2548
DOI:10.1126/sciadv.abb5093